- Home
- AGIO vs TALO Comparison
AGIO vs TALO Comparison
Compare AGIO & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- TALO
- Stock Information
- Founded
- AGIO 2007
- TALO 2011
- Country
- AGIO United States
- TALO United States
- Employees
- AGIO N/A
- TALO N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- TALO Oil & Gas Production
- Sector
- AGIO Health Care
- TALO Energy
- Exchange
- AGIO Nasdaq
- TALO Nasdaq
- Market Cap
- AGIO 1.4B
- TALO 1.5B
- IPO Year
- AGIO 2013
- TALO N/A
- Fundamental
- Price
- AGIO $39.23
- TALO $8.90
- Analyst Decision
- AGIO Buy
- TALO Buy
- Analyst Count
- AGIO 6
- TALO 8
- Target Price
- AGIO $58.60
- TALO $14.25
- AVG Volume (30 Days)
- AGIO 615.0K
- TALO 3.1M
- Earning Date
- AGIO 07-31-2025
- TALO 08-06-2025
- Dividend Yield
- AGIO N/A
- TALO N/A
- EPS Growth
- AGIO N/A
- TALO N/A
- EPS
- AGIO 11.45
- TALO 0.14
- Revenue
- AGIO $37,035,000.00
- TALO $2,055,748,000.00
- Revenue This Year
- AGIO $22.30
- TALO N/A
- Revenue Next Year
- AGIO $219.19
- TALO N/A
- P/E Ratio
- AGIO $3.39
- TALO $61.69
- Revenue Growth
- AGIO 25.96
- TALO 31.54
- 52 Week Low
- AGIO $23.42
- TALO $6.23
- 52 Week High
- AGIO $62.58
- TALO $12.71
- Technical
- Relative Strength Index (RSI)
- AGIO 70.51
- TALO 57.96
- Support Level
- AGIO $34.60
- TALO $8.58
- Resistance Level
- AGIO $40.06
- TALO $9.11
- Average True Range (ATR)
- AGIO 1.45
- TALO 0.38
- MACD
- AGIO 0.43
- TALO 0.00
- Stochastic Oscillator
- AGIO 88.98
- TALO 54.95
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About TALO Talos Energy Inc.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.